Growth factors, inflammatory cytokines and postnatal bone strength in preterm infants

Alon Eliakim1, Dan Nemet, Irfan Ahmad

  • 1Child Health and Sports Center, Pediatric Department, Meir Medical Center, Kfar Saba, Israel. eliakim.alon@clalit.org.il

Insights

Preterm infants

Area of Science:

  • Neonatal physiology and bone development
  • Pediatric endocrinology and immunology

Background:

  • Preterm infants exhibit unique challenges in postnatal bone development.
  • Growth factors and inflammatory cytokines play critical roles in bone metabolism.
  • Understanding these relationships is crucial for optimizing bone health in vulnerable neonates.

Purpose of the Study:

  • To investigate the association between growth factors, inflammatory cytokines, and bone development in preterm infants.
  • To determine how serum levels of IGF-I, GHBP, IL-6, and IL-1RA correlate with bone strength progression.

Main Methods:

  • Fifty preterm infants (24-32 weeks GA) were monitored weekly for bone strength using quantitative ultrasound (bone speed of sound - SOS).
  • Serum samples were analyzed for insulin-like growth factor-I (IGF-I), GH binding protein (GHBP), interleukin-6 (IL-6), and IL-1 receptor antagonist (IL-1RA).
  • Infants were categorized into bone gainers and bone losers based on changes in bone SOS.

Main Results:

  • Despite overall growth, bone SOS significantly decreased in the cohort.
  • Growth factors increased and inflammatory cytokines decreased during follow-up.
  • Infants with lower baseline bone SOS and lower IL-6 levels showed improved bone strength (bone gainers).

Conclusions:

  • Preterm infants with initially lower bone SOS demonstrate a 'catch-up' growth pattern in bone strength.
  • Reduced inflammation, indicated by lower IL-6 levels, is associated with improved bone strength gain in preterm infants.
  • These findings highlight the interplay between inflammatory status and skeletal development in neonates.
Abstract

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...